Literature DB >> 15793036

Recent insights into the interactions between the baroreflex and the kidneys in hypertension.

Thomas E Lohmeier1, Drew A Hildebrandt, Susan Warren, Paul J May, J Thomas Cunningham.   

Abstract

Recent findings in chronically instrumented animals challenge the classic concept that baroreflexes do not play a role in the chronic regulation of arterial pressure. As alterations in renal excretory function are of paramount importance in the chronic regulation of arterial pressure, several of these recent studies have focused on the long-term interactions between the baroreflex and the kidneys during chronic perturbations in arterial pressure and body fluid volumes. An emerging body of evidence indicates that the baroreflex is chronically activated in several experimental models of hypertension, but in most cases, the duration of these studies has not exceeded 2 wk. Although these studies suggest that the baroreflex may play a compensatory role in attenuating the severity of the hypertension, possibly even in primary hypertension with uncertain causes of sympathetic activation, there has been only limited assessment of the quantitative importance of this interaction in the regulation of arterial pressure. In experimental models of secondary hypertension, baroreflex suppression of renal sympathetic nerve activity is sustained and chronically promotes sodium excretion. This raises the possibility that the renal nerves may be the critical efferent link for baroreceptor-induced suppression of central sympathetic output through which long-term compensatory reductions in arterial pressure are produced. This contention is supported by strong theoretical evidence but must be corroborated by experimental studies. Finally, although it is now clear that pressure-induced increases in baroreflex activity persist for longer periods of time than previously suggested, studies using new tools and novel approaches and extending beyond 2 wk of hypertension are needed to elucidate the true role of the baroreflex in the pathogenesis of clinical hypertension.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15793036     DOI: 10.1152/ajpregu.00591.2004

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  29 in total

Review 1.  Renal sympathetic nerve activity in the development of hypertension.

Authors:  Simon C Malpas; Rohit Ramchandra; Sarah-Jane Guild; Fiona McBryde; Carolyn J Barrett
Journal:  Curr Hypertens Rep       Date:  2006-06       Impact factor: 5.369

2.  Baroreflex device therapy in the treatment of hypertension.

Authors:  Sarada C Uppuluri; Eugene Storozynsky; John D Bisognano
Journal:  Curr Hypertens Rep       Date:  2009-02       Impact factor: 5.369

3.  Dynamic transcriptomic response to acute hypertension in the nucleus tractus solitarius.

Authors:  Rishi L Khan; Rajanikanth Vadigepalli; Mary K McDonald; Robert F Rogers; Guang R Gao; James S Schwaber
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-04-23       Impact factor: 3.619

Review 4.  The baroreflex as a long-term controller of arterial pressure.

Authors:  Thomas E Lohmeier; Radu Iliescu
Journal:  Physiology (Bethesda)       Date:  2015-03

5.  Dissociation of hyperglycemia from altered vascular contraction and relaxation mechanisms in caveolin-1 null mice.

Authors:  Luminita H Pojoga; Tham M Yao; Lauren A Opsasnick; Amanda E Garza; Ossama M Reslan; Gail K Adler; Gordon H Williams; Raouf A Khalil
Journal:  J Pharmacol Exp Ther       Date:  2013-11-26       Impact factor: 4.030

6.  Current computational models do not reveal the importance of the nervous system in long-term control of arterial pressure.

Authors:  John W Osborn; Viktoria A Averina; Gregory D Fink
Journal:  Exp Physiol       Date:  2009-04       Impact factor: 2.969

7.  Prolonged activation of the baroreflex decreases arterial pressure even during chronic adrenergic blockade.

Authors:  Thomas E Lohmeier; Drew A Hildebrandt; Terry M Dwyer; Radu Iliescu; Eric D Irwin; Adam W Cates; Martin A Rossing
Journal:  Hypertension       Date:  2009-03-09       Impact factor: 10.190

Review 8.  The sympathetic nervous system in obesity hypertension.

Authors:  Thomas E Lohmeier; Radu Iliescu
Journal:  Curr Hypertens Rep       Date:  2013-08       Impact factor: 5.369

9.  Lowering of blood pressure during chronic suppression of central sympathetic outflow: insight from computer simulations.

Authors:  Radu Iliescu; Thomas E Lohmeier
Journal:  Clin Exp Pharmacol Physiol       Date:  2009-09-21       Impact factor: 2.557

Review 10.  Regulation of central angiotensin type 1 receptors and sympathetic outflow in heart failure.

Authors:  Irving H Zucker; Harold D Schultz; Kaushik P Patel; Wei Wang; Lie Gao
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-08-28       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.